Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Jardiance Filed for Chronic Heart Failure in Japan: BI/Lilly
November 30, 2020
- Sales Rep Promotions Up in All Channels in September: Intage
November 30, 2020
- Takeda Seeks Japan Nod for Zejula Tablet Form
November 27, 2020
- COVID-19 Pandemic Could Have Negative Impact of Up to 170 Billion Yen on Japan Drug Market in FY2020: IQVIA
November 27, 2020
- Relugolix Nets Positive PIII Data in Endometriosis, ASKA Set to Seek Add’l Use in H1 2021
November 26, 2020
- Vibegron Fails in US PII Trial for IBS Pain: Urovant
November 26, 2020
- Shionogi, Nagasaki Univ., Kitasato Institute Join Forces on Antimalarial Drug Research
November 26, 2020
- Dupixent Auto-Injector Now Available: Sanofi
November 26, 2020
- Nippon Shinyaku Files Uptravi for CTEPH
November 26, 2020
- Takeda to Take Full Control of Nihon Pharm as Plasma Biz Grows
November 25, 2020
- Improved Hygiene amid COVID-19 Hit Infectious Disease Meds, Big-Seller Hopefuls See Slow Uptake
November 24, 2020
- Takeda Launches Zejula, 2nd PARP Inhibitor in Japan
November 24, 2020
- Big 3 Generic Makers Log 7.2% Growth in 1st Half, Suffer Sluggish Japan Sales on Price Cuts, COVID-19: Jiho Tally
November 20, 2020
- Gilead’s JAK Med Hits Shelves in Japan; Launch Being Prepped for Oral Semaglutide, Rakuten Photoimmunotherapy
November 19, 2020
- Kyowa Kirin/Sandoz’s Rituxan Biosimilar Expands Label
November 19, 2020
- Half of Patients Postpone or Cancel Regular Checkups amid COVID-19: Roche Survey
November 19, 2020
- Number of Patients Treated by Pediatricians Shows Sharp Rebound in October: Survey
November 19, 2020
- 20% of Osteoporosis Patients Reduce/Halt Clinic Visits Amid COVID-19 Pandemic: Survey
November 19, 2020
- Daiichi Sankyo, CureApp Link Up on Cancer Treatment Support App, Eye Clinical Study in FY2021
November 19, 2020
- Nichi-Iko Files Avastin Biosimilar in Japan
November 19, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…